Nuclear stocks OKLO, XE, and NuScale slid as investors demanded real results over AI hype, signaling skepticism about near-term SMR deployment.

Nuclear stocks OKLO, XE, and NuScale slid as investors demanded real results over AI hype, signaling skepticism about near-term SMR deployment.

Nuclear baseload investments are now subject to execution and commercialization timelines; only credible build-out timelines will command premium valuations.